Plasminogen activator inhibitor-1 (PAI-1) but not fibrinogen and CRP were found to predict type 2 diabetes in the Insulin Resistance Atherosclerosis Study, IRAS [5]. This evidence concerns the gene CRP and type 2 diabetes mellitus.